179 related articles for article (PubMed ID: 28036297)
21. Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells.
Waha A; Felsberg J; Hartmann W; von dem Knesebeck A; Mikeska T; Joos S; Wolter M; Koch A; Yan PS; Endl E; Wiestler OD; Reifenberger G; Pietsch T; Waha A
Cancer Res; 2010 Feb; 70(4):1689-99. PubMed ID: 20124482
[TBL] [Abstract][Full Text] [Related]
22. 2-HG Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 Promoter.
Yang Z; Jiang B; Wang Y; Ni H; Zhang J; Xia J; Shi M; Hung LM; Ruan J; Mak TW; Li Q; Han J
Cell Rep; 2017 May; 19(9):1846-1857. PubMed ID: 28564603
[TBL] [Abstract][Full Text] [Related]
23. Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas.
Chen R; Ravindra VM; Cohen AL; Jensen RL; Salzman KL; Prescot AP; Colman H
Neurosurg Focus; 2015 Mar; 38(3):E2. PubMed ID: 25727224
[TBL] [Abstract][Full Text] [Related]
24. TGF-β-mediated repression of MST1 by DNMT1 promotes glioma malignancy.
Guo Z; Li G; Bian E; Ma CC; Wan J; Zhao B
Biomed Pharmacother; 2017 Oct; 94():774-780. PubMed ID: 28802229
[TBL] [Abstract][Full Text] [Related]
25. Wnt signaling pathway upregulates DNMT1 to trigger NHERF1 promoter hypermethylation in colon cancer.
Guo Y; Wang M; Jia X; Zhu H; Zhi Y; Yuan L
Oncol Rep; 2018 Aug; 40(2):1165-1173. PubMed ID: 29901158
[TBL] [Abstract][Full Text] [Related]
26. Identification of DBCCR1 as a suppressor in the development of lung cancer that is associated with increased DNA methyltransferase 1.
Zhou G; Ye J; Fang Y; Zhang Z; Zhang J; Sun L; Feng J
Oncotarget; 2017 May; 8(20):32821-32832. PubMed ID: 28427182
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas.
Li J; Taich ZJ; Goyal A; Gonda D; Akers J; Adhikari B; Patel K; Vandenberg S; Yan W; Bao Z; Carter BS; Wang R; Mao Y; Jiang T; Chen CC
Oncotarget; 2014 Sep; 5(17):7342-56. PubMed ID: 25277177
[TBL] [Abstract][Full Text] [Related]
28. Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma.
Bao Z; Feng Y; Wang H; Zhang C; Sun L; Yan Z; Liu Q; Guo T; Li M; Yang X; Jiang C; Zhang Q; Jiang T
Oncol Rep; 2014 Jul; 32(1):250-60. PubMed ID: 24842301
[TBL] [Abstract][Full Text] [Related]
29. LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients.
Mock A; Geisenberger C; Orlik C; Warta R; Schwager C; Jungk C; Dutruel C; Geiselhart L; Weichenhan D; Zucknick M; Nied AK; Friauf S; Exner J; Capper D; Hartmann C; Lahrmann B; Grabe N; Debus J; von Deimling A; Popanda O; Plass C; Unterberg A; Abdollahi A; Schmezer P; Herold-Mende C
Int J Cancer; 2016 Jul; 139(2):424-32. PubMed ID: 26934681
[TBL] [Abstract][Full Text] [Related]
30. Targeting EP4 downstream c-Jun through ERK1/2-mediated reduction of DNMT1 reveals novel mechanism of solamargine-inhibited growth of lung cancer cells.
Chen Y; Tang Q; Xiao Q; Yang L; Hann SS
J Cell Mol Med; 2017 Feb; 21(2):222-233. PubMed ID: 27620163
[TBL] [Abstract][Full Text] [Related]
31. Frequent epigenetic inactivation of the chaperone SGNE1/7B2 in human gliomas.
Waha A; Felsberg J; Hartmann W; Hammes J; von dem Knesebeck A; Endl E; Pietsch T; Waha A
Int J Cancer; 2012 Aug; 131(3):612-22. PubMed ID: 21901745
[TBL] [Abstract][Full Text] [Related]
32. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation.
Costello JF; Berger MS; Huang HS; Cavenee WK
Cancer Res; 1996 May; 56(10):2405-10. PubMed ID: 8625319
[TBL] [Abstract][Full Text] [Related]
33. Insulator dysfunction and oncogene activation in IDH mutant gliomas.
Flavahan WA; Drier Y; Liau BB; Gillespie SM; Venteicher AS; Stemmer-Rachamimov AO; Suvà ML; Bernstein BE
Nature; 2016 Jan; 529(7584):110-4. PubMed ID: 26700815
[TBL] [Abstract][Full Text] [Related]
34. DNMT1-mediated regulating on FBXO32 promotes the progression of glioma cells through the regulation of SKP1 activity.
Quan J; Ma C
Environ Toxicol; 2024 Feb; 39(2):783-793. PubMed ID: 37782699
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of DNMT1 and ERRα crosstalk suppresses breast cancer via derepression of IRF4.
Vernier M; McGuirk S; Dufour CR; Wan L; Audet-Walsh E; St-Pierre J; Giguère V
Oncogene; 2020 Oct; 39(41):6406-6420. PubMed ID: 32855526
[TBL] [Abstract][Full Text] [Related]
36. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS
Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707
[TBL] [Abstract][Full Text] [Related]
37. CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas.
Paz MF; Yaya-Tur R; Rojas-Marcos I; Reynes G; Pollan M; Aguirre-Cruz L; García-Lopez JL; Piquer J; Safont MJ; Balaña C; Sanchez-Cespedes M; García-Villanueva M; Arribas L; Esteller M
Clin Cancer Res; 2004 Aug; 10(15):4933-8. PubMed ID: 15297393
[TBL] [Abstract][Full Text] [Related]
38. Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.
Viotti J; Duplan E; Caillava C; Condat J; Goiran T; Giordano C; Marie Y; Idbaih A; Delattre JY; Honnorat J; Checler F; Alves da Costa C
Oncogene; 2014 Apr; 33(14):1764-75. PubMed ID: 23644658
[TBL] [Abstract][Full Text] [Related]
39. Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications.
Malta TM; de Souza CF; Sabedot TS; Silva TC; Mosella MS; Kalkanis SN; Snyder J; Castro AVB; Noushmehr H
Neuro Oncol; 2018 Apr; 20(5):608-620. PubMed ID: 29036500
[TBL] [Abstract][Full Text] [Related]
40. Alternative pathway of transcriptional induction of p21WAF1/Cip1 by cyclosporine A in p53-deficient human glioblastoma cells.
Zupanska A; Adach A; Dziembowska M; Kaminska B
Cell Signal; 2007 Jun; 19(6):1268-78. PubMed ID: 17321721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]